By creating a free Inderes account, you get access to Inderes analysis, you can order the popular morning review and follow companies and discussions that interest you.
Already have an account?
Follow this company like 11047 other investors.
Analyytikko
Remedy Entertainment Plc | Stock Exchange Release | March 20, 2023, at 2.15 p.m. (EET)Notice to the Annual General Meeting of Remedy Entertainment PlcShareholders of Remedy Entertainment Plc are summoned to the company's Annual General Meeting, which will be held on Thursday April 13, 2023, starting at 09:00 a.m. (EEST) at the company's office at Luomanportti 3, 02200 Espoo, Finland.The reception of attendees who have preregistered for the meeting will commence at 8:30 a.m. (EEST) on the meeting venue.
Remedy Entertainment Plc | Stock Exchange Release | March 20, 2023, at 2.15 p.m. (EET)
Notice to the Annual General Meeting of Remedy Entertainment Plc
Shareholders of Remedy Entertainment Plc are summoned to the company's Annual General Meeting, which will be held on Thursday April 13, 2023, starting at 09:00 a.m. (EEST) at the company's office at Luomanportti 3, 02200 Espoo, Finland.
The reception of attendees who have preregistered for the meeting will commence at 8:30 a.m. (EEST) on the meeting venue.
Remedy Entertainment Plc | Stock Exchange Release, March 20, 2023, at 2 p.m. (EET)
Remedy Entertainment PLC's Annual Report 2022, Financial Statement, Remuneration Policy, Remuneration Report and Corporate Governance Statement have been published
Redeye has postponed the expected release of the free-to-play game codenamed Vanguard in its research update. In our new assumptions Remedy will rely on premium games and one smaller game within the “games as a service” business model until 2026. This makes our estimate less uncertain during a 3-4 year period, which lowers the investment risk we ague.
Read more and download the Research Update.
There were no major surprises in the company's Q4 figures and, as expected, the outlook for 2023 is still weak in light of the figures. This year, Remedy is still clearly in an investment phase as the company builds its strategy for the next growth leap with 5 major gaming projects under development.
Remedy reported slightly better-than-expected Q4 figures this morning. Based on the outlook, the company's revenue and earnings are expected to decline this year, ahead of the earnings growth phase that will start with the release of Alan Wake 2 at the end of the year.
Remedy Entertainment Plc | Financial Statements Release, February 10, 2023, at 09:00 a.m. (EET)Remedy Entertainment Plc | Financial Statements Release 2022Games roadmap fortified for future growthInvestments in game projects accelerated and new deals strengthened the portfolio with first of the major new game launches in sight for 2023Figures in parentheses refer to the comparison period in the previous year, unless otherwise stated.
Remedy Entertainment Plc | Financial Statements Release, February 10, 2023, at 09:00 a.m. (EET)
Remedy Entertainment Plc | Financial Statements Release 2022
Games roadmap fortified for future growth
Investments in game projects accelerated and new deals strengthened the portfolio with first of the major new game launches in sight for 2023
Figures in parentheses refer to the comparison period in the previous year, unless otherwise stated.
Remedy Entertainment Plc | Stock exchange release January 30, 2023, 10.30 a.m. (EET)
Share subscriptions based on stock options 2018 and 2019
Between September 16 and December 31, 2022, a total of 20,500 Remedy Entertainment Plc's new shares has been subscribed for with the company's stock options 2018 and 2019. For subscriptions made with the stock options 2018 and 2019, the entire subscription price of EUR 183,690.00 will be entered in the reserve for invested unrestricted equity.
After the trade registration the total amount of shares is 13,469,100.
Remedy Entertainment Oyj - Managers' Transactions January 13, 2023 at 8:45 a.m. (EET)
____________________________________________
Person subject to the notification requirement
Name: Sami Järvi
Position: Other senior manager
Issuer: Remedy Entertainment Oyj
LEI: 7437003VZ3JPF7DBTG92
Notification type: INITIAL NOTIFICATION
Reference number: 24352/6/6
Transaction date: 2023-01-12
Outside a trading venue
Name: Christopher Schmitz
Reference number: 24359/6/6
Name: Tero Virtala
Position: Chief Executive Officer
Reference number: 24346/6/6
